Corteva to Separate Its Seed Business into an Independent Company
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 01 2025
0mins
Should l Buy KHC?
Source: WSJ
Corteva's Business Strategy: Corteva plans to split its seed and pesticide businesses into two distinct companies.
Market Valuation: The company had a market value of approximately $46 billion as of Tuesday, confirming earlier reports from the Wall Street Journal.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KHC
Wall Street analysts forecast KHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KHC is 25.86 USD with a low forecast of 24.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
0 Buy
14 Hold
1 Sell
Hold
Current: 24.640
Low
24.00
Averages
25.86
High
28.00
Current: 24.640
Low
24.00
Averages
25.86
High
28.00
About KHC
The Kraft Heinz Company manufactures and markets food and beverage products around the world through its eight consumer-driven product platforms: Taste Elevation, Easy Ready Meals, Substantial Snacking, Desserts, Hydration, Cheese, Coffee, and Meats. The Company has two reportable segments defined by geographic region: North America and International Developed Markets. Its other segments, consisting of West and East Emerging Markets (WEEM) and Asia Emerging Markets (AEM), are combined and disclosed as Emerging Markets. It manufactures its products from a wide variety of raw materials. Its brands include Kraft, Oscar Mayer, Heinz, Philadelphia, Lunchables, Velveeta, Ore-Ida, Capri Sun, Maxwell Apartment, Kool-Aid, Jell-O, Heinz, Golden Circle, Wattie’s, Plasmon, Heinz, ABC, Master, Quero, Kraft, and Pudliszki, among others. The Company’s products are sold through its own sales organizations and through independent brokers, agents, and distributors.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Schedule: This week features a high volume of earnings reports from technology, consumer discretionary, and energy sectors, with RIVN stock showing notable movement ahead of its earnings release, indicating investor sentiment.
- Monday.com and Pagaya Reports: On Monday, work management SaaS provider Monday.com and fintech company Pagaya released their earnings before the market opened, with expectations that their results will reflect broader industry trends.
- Coinbase Earnings Expectations: On Thursday, Coinbase is expected to report earnings of 68 cents per share and quarterly revenue of $1.86 billion, despite facing a projected 33% drop in transaction revenue, raising investor interest in its growing stablecoin and subscription services.
- Nebius Group Forecast: Also on Thursday, Nebius Group is projected to report a loss of $1.14 per share and revenue of $246.05 million, with analysts expressing caution, reflecting concerns over cloud service demand in the current market environment.
See More
- Buffett's Investment Philosophy: Buffett's strategy of buying well-managed companies for the long term has faced challenges, as seen in his investment in Kraft Heinz, illustrating that even successful investors can make mistakes.
- Kraft Heinz Split Plan: Kraft Heinz's decision to abandon its merger and split again may not significantly improve financial performance, highlighting that merging struggling companies does not necessarily create a strong entity.
- Coca-Cola's Stability: Coca-Cola, a long-term holding for Buffett, continues to attract investors with a 2.6% dividend yield and strong market performance, reinforcing its leadership position in the consumer staples sector.
- Market Selection Advice: With the market near all-time highs, investors should prioritize quality stocks; Kraft Heinz's uncertain outlook contrasts with Coca-Cola, which is viewed as a more attractive investment option.
See More

- Stock Market Trends: Stock futures were declining on Monday as investors expressed concerns about the sustainability of a recent relief rally.
- Investor Sentiment: There is a prevailing uncertainty among investors regarding the market's ability to maintain upward momentum following last week's gains.
See More
- Buffett's Leadership Achievements: Buffett served as CEO of Berkshire Hathaway from 1965, achieving an average annual stock price increase of about 20%, significantly outperforming the S&P 500's 10.3%, highlighting the success and sustainability of his investment strategies.
- Signs of DaVita's Recovery: DaVita exceeded expectations in its latest quarterly results and provided 2026 earnings guidance between $13.60 and $15, with shares surging over 30% since the earnings release, indicating restored market confidence and future growth potential.
- Investment Opportunity in Kraft Heinz: Despite Berkshire's losses in Kraft Heinz, the current market cap of around $7.5 billion and a forward P/E of 9 attract new investors, especially as the company plans to split to unlock value, reminiscent of Kellogg's successful separation strategy.
- Cautious Stance on UnitedHealth Group: Although Berkshire purchased 5 million shares last year, the stock has fallen from $350 to around $280 due to lower-than-expected Medicare payment increases, prompting investors to think twice before buying the dip given the potential for further multiple compression.
See More
- Strong Earnings Performance: DaVita's latest quarterly results exceeded expectations, with projected earnings per share between $13.60 and $15 for 2026, resulting in a current price-to-earnings ratio of only 9 times, indicating potential for future growth and attracting investor interest.
- Stock Price Rebound: Since the earnings release, DaVita's stock has surged over 30%, reflecting market recognition of its performance and potentially providing room for multiple expansion, as it previously traded at 13 to 14 times forward earnings.
- Buffett's Investment Strategy: Despite Berkshire Hathaway's losses on its Kraft Heinz investment, currently valued at around $7.5 billion, the planned split into two entities may present opportunities for new investors, especially as Kraft Heinz trades at a mere 9 times forward earnings, below peers.
- Healthcare Sector Challenges: UnitedHealth Group's stock has fallen from $350 to around $280, primarily due to the U.S. government's lower-than-expected Medicare payment increases; although Buffett had previously purchased shares, the current 16 times forward earnings ratio indicates market concerns about its growth trajectory, warranting caution for investors.
See More
- Buffett's Investment Returns: From 1965 to 2025, Berkshire Hathaway achieved an average annual return of approximately 20%, significantly outperforming the S&P 500's 10.3%, indicating Buffett's investment strategy has excelled over the long term, reinforcing the company's market leadership.
- Signs of DaVita's Recovery: DaVita exceeded expectations in its latest quarterly results and projected earnings per share between $13.60 and $15 for 2026, with shares surging over 30% since the earnings release, presenting an opportunity for investors to reassess its value, especially as it historically traded at 13 to 14 times forward earnings.
- Investment Opportunity in Kraft Heinz: Despite Berkshire's losses in Kraft Heinz, the stock currently trades at a mere 9 times forward earnings, below peers, and the company's plan to split into two entities could unlock significant value, attracting new investors' interest.
- Cautious Approach to UnitedHealth Group: Although Berkshire purchased 5 million shares of UnitedHealth last year, the stock has dropped from $350 to around $280 due to lower-than-expected Medicare payment increases, with a current P/E ratio of 16, which is still above peers, prompting investors to consider their buying strategy carefully.
See More










